west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "中晚期肝癌" 2 results
  • GUIDED CHEMOEMBOLIZATION THERAPY FOR MODERATE AND ADVANCED CARCINOMA OF LIVER USING ADRIAMYCIN LIPIODOL EMULSION (A REPORT OF 884 CASES)

    We have performed guided chemoembolization on 84 patients of moderate and advanced carcinoma of liver using adriamycin lipiodol emulsion (A/L) since 1986. Result showed that the rate of improvement of symptoms was 86.1%, in 75% cases the AFP were decreased and in 79.2% the size of tumor were reduced. The mean survival time was 10.3 months which was much higher than that of the control group (5.6 months,Plt;0.001). THe survival rates of 1/2,1,2,3 year were 89.3%,43.4%,13.5% and 3.8% respctively that were significantly higher than those of the control group (51.2%, 11.5%,0) (Plt;0.01). Three patients underwent secondary resection after using A/L chemoembolization ans gelatin spinge central embolization with a longer survival rate. This may be a good method of treatment to the nonresectable liver cancers and may also be an easy way for postoperative observation.

    Release date:2016-08-29 03:44 Export PDF Favorites Scan
  • Double Interventions in Treatment of Advanced Liver Cancer (Report of 175 Cases)

    目的 应用联合微创介入方法治疗中晚期肝癌并探讨其疗效。方法 我院自1998年4月至2008年11月期间采用联合介入治疗的方法,即行经皮股动脉插管肝动脉化疗栓塞术,同期行B超引导下经皮穿刺瘤内乙醇注射(PEI)治疗中晚期肝癌175例。结果 左肝动脉行肝动脉化疗栓塞7例,右肝动脉行125例,单行化疗而未栓塞43例; 175例均行B超引导下PEI。随访6~28个月,平均19.3个月,死亡15例,其中8例死于肝功能衰竭,7例死于上消化道大出血伴肝癌广泛转移。29例存活6~12个月; 146例存活13~28个月,其中27例存活已超过26个月。结论 对于不能切除的中晚期肝癌采用联合介入治疗,因其具有操作简单、疗效可靠、经济、安全等优点,值得临床推广应用。

    Release date:2016-09-08 10:54 Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content